Literature DB >> 3430546

The clinical features of Ehlers-Danlos syndrome type VII due to a deletion of 24 amino acids from the pro alpha 1(I) chain of type I procollagen.

W G Cole1, R Evans, D O Sillence.   

Abstract

The clinical features and progress of a child with the type VII form of Ehlers-Danlos syndrome due to a deletion in the pro alpha 1(I) of type I procollagen were studied. The child was born with bilateral dislocations of hips and knees and all other joints were markedly hypermobile. Persistent severe joint instability was the major clinical abnormality. She had a depressed nasal bridge with prominent paranasal folds and deeply set eyes with mild hypertelorism and micrognathia. The skin was soft, moderately hyperelastic, and sagged over the face and knees. Skin fragility and easy bruising appeared when she started walking. Electron microscopy of the dermis showed irregular collagen fibrils.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3430546      PMCID: PMC1050350          DOI: 10.1136/jmg.24.11.698

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

1.  Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII.

Authors:  W G Cole; D Chan; G W Chambers; I D Walker; J F Bateman
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

2.  Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome.

Authors:  J R Lichtenstein; G R Martin; L D Kohn; P H Byers; V A McKusick
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

3.  Procollagen peptidase deficiency in a form of the Ehlers-Danlos syndrome.

Authors:  J R Lichtenstein; L D Kohn; G R Martin; P Byers; V A McKusick
Journal:  Trans Assoc Am Physicians       Date:  1973

Review 4.  Heritable diseases of collagen.

Authors:  D J Prockop; K I Kivirikko
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

5.  A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.

Authors:  D R Eyre; F D Shapiro; J F Aldridge
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

6.  Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.

Authors:  B Steinmann; L Tuderman; L Peltonen; G R Martin; V A McKusick; D J Prockop
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

  6 in total
  7 in total

Review 1.  Ehlers-Danlos syndrome has varied molecular mechanisms.

Authors:  F M Pope; N P Burrows
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

Review 2.  Dysmorphic syndromes with demonstrable biochemical abnormalities.

Authors:  P T Clayton; E Thompson
Journal:  J Med Genet       Date:  1988-07       Impact factor: 6.318

3.  A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

Authors:  Robert C Gensure; Outi Mäkitie; Catherine Barclay; Catherine Chan; Steven R Depalma; Murat Bastepe; Hilal Abuzahra; Richard Couper; Stefan Mundlos; David Sillence; Leena Ala Kokko; Jonathan G Seidman; William G Cole; Harald Jüppner
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 4.  The "other" 15-40%: The Role of Non-Collagenous Extracellular Matrix Proteins and Minor Collagens in Tendon.

Authors:  Nandaraj Taye; Stylianos Z Karoulias; Dirk Hubmacher
Journal:  J Orthop Res       Date:  2019-08-26       Impact factor: 3.494

5.  Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.

Authors:  Kazuhiko Takahara; Ulrike Schwarze; Yasutada Imamura; Guy G Hoffman; Helga Toriello; Lynne T Smith; Peter H Byers; Daniel S Greenspan
Journal:  Am J Hum Genet       Date:  2002-07-17       Impact factor: 11.025

6.  Ehlers-Danlos syndrome type IV: phenotypic consequences of a splicing mutation in one COL3A1 allele.

Authors:  D O Sillence; A A Chiodo; P E Campbell; W G Cole
Journal:  J Med Genet       Date:  1991-12       Impact factor: 6.318

7.  The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.

Authors:  A J Carr; A A Chiodo; J M Hilton; C W Chow; A Hockey; W G Cole
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.